25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BioRestorative Therapies Inc
Buy, Hold or Sell?

Let's analyze Biorestorative together

I guess you are interested in BioRestorative Therapies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioRestorative Therapies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioRestorative Therapies Inc

I send you an email if I find something interesting about BioRestorative Therapies Inc.

1. Quick Overview

1.1. Quick analysis of Biorestorative (30 sec.)










1.2. What can you expect buying and holding a share of Biorestorative? (30 sec.)

How much money do you get?

How much money do you get?
$0.09
When do you have the money?
1 year
How often do you get paid?
5.1%

What is your share worth?

Current worth
$1.23
Expected worth in 1 year
$0.40
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
$-0.75
Return On Investment
-49.7%

For what price can you sell your share?

Current Price per Share
$1.50
Expected price per share
$1.03 - $1.8
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biorestorative (5 min.)




Live pricePrice per Share (EOD)
$1.50
Intrinsic Value Per Share
$-11.74 - $-7.31
Total Value Per Share
$-10.51 - $-6.08

2.2. Growth of Biorestorative (5 min.)




Is Biorestorative growing?

Current yearPrevious yearGrowGrow %
How rich?$9.9m$13.6m-$1.8m-15.9%

How much money is Biorestorative making?

Current yearPrevious yearGrowGrow %
Making money-$2.4m-$3.1m$675.6k27.6%
Net Profit Margin-3,780.3%-31,527.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Biorestorative (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#630 / 949

Most Revenue
#660 / 949

Most Profit
#325 / 949

Most Efficient
#809 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biorestorative?

Welcome investor! Biorestorative's management wants to use your money to grow the business. In return you get a share of Biorestorative.

First you should know what it really means to hold a share of Biorestorative. And how you can make/lose money.

Speculation

The Price per Share of Biorestorative is $1.5. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biorestorative.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biorestorative, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.23. Based on the TTM, the Book Value Change Per Share is $-0.21 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biorestorative.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-9.0%-0.32-21.1%-0.38-25.0%-0.68-45.7%-0.53-35.4%
Usd Book Value Change Per Share-0.10-6.6%-0.21-13.8%-0.15-10.1%0.1610.6%0.063.7%
Usd Dividend Per Share0.042.8%0.021.4%0.000.0%0.000.2%0.000.1%
Usd Total Gains Per Share-0.06-3.8%-0.19-12.4%-0.15-10.1%0.1610.8%0.063.8%
Usd Price Per Share1.74-1.72-3.09-1.75-2.11-
Price to Earnings Ratio-3.24--1.78--10.70--2.77--2.31-
Price-to-Total Gains Ratio-30.31--9.24--6.28--5.49-1,292.65-
Price to Book Ratio1.41-1.20-1.59-0.82--1.37-
Price-to-Total Gains Ratio-30.31--9.24--6.28--5.49-1,292.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.5
Number of shares666
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.00
Usd Book Value Change Per Share-0.210.16
Usd Total Gains Per Share-0.190.16
Gains per Quarter (666 shares)-124.17108.32
Gains per Year (666 shares)-496.67433.28
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
157-553-5079424423
2113-1107-100418849856
3170-1660-15012712731289
4227-2214-19983616971722
5284-2767-24954521222155
6340-3320-29925425462588
7397-3874-34896329703021
8454-4427-39867233953454
9511-4981-44838138193887
10567-5534-49809042434320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%1.018.00.05.3%1.038.00.02.6%1.051.06.01.7%
Book Value Change Per Share1.02.00.033.3%3.08.00.027.3%6.013.00.031.6%13.026.00.033.3%17.041.00.029.3%
Dividend per Share2.00.01.066.7%2.00.09.018.2%2.00.017.010.5%2.00.037.05.1%3.00.055.05.2%
Total Gains per Share1.02.00.033.3%3.08.00.027.3%6.013.00.031.6%13.026.00.033.3%17.041.00.029.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioRestorative Therapies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.099-0.208+109%-0.151+52%0.159-162%0.055-279%
Book Value Per Share--1.2301.552-21%1.971-38%0.520+137%-0.225+118%
Current Ratio--2.9493.544-17%22.467-87%13.497-78%6.596-55%
Debt To Asset Ratio--0.3140.279+13%0.054+480%3.758-92%4.444-93%
Debt To Equity Ratio--0.4590.396+16%0.058+696%0.084+446%0.041+1020%
Dividend Per Share--0.0420.021+97%-+100%0.003+1148%0.002+2463%
Enterprise Value--22637734.26023668233.610-4%33342632.000-32%14682556.574+54%11758050.345+93%
Eps---0.134-0.317+136%-0.375+179%-0.685+410%-0.530+295%
Ev To Ebitda Ratio---2.475-2.176-12%-2.132-14%inf+inf%nannan%
Ev To Sales Ratio--24.22785.868-72%719.023-97%294.959-92%242.660-90%
Free Cash Flow Per Share---0.205-0.258+26%-0.237+15%-0.186-9%-0.179-13%
Free Cash Flow To Equity Per Share---0.2050.104-298%-0.125-39%0.422-149%0.217-194%
Gross Profit Margin--1.0000.998+0%1.0000%1.0010%1.009-1%
Intrinsic Value_10Y_max---7.315--------
Intrinsic Value_10Y_min---11.739--------
Intrinsic Value_1Y_max---0.719--------
Intrinsic Value_1Y_min---0.972--------
Intrinsic Value_3Y_max---2.172--------
Intrinsic Value_3Y_min---3.116--------
Intrinsic Value_5Y_max---3.637--------
Intrinsic Value_5Y_min---5.455--------
Market Cap10379880.000-36%14131408.26013389180.277+6%21365253.000-34%12366161.100+14%14717574.191-4%
Net Profit Margin---4.672-37.803+709%-315.275+6648%-363.373+7677%-245.774+5160%
Operating Margin----48.3720%-400.3200%-370.1350%-238.1490%
Operating Ratio--10.79052.635-80%402.771-97%214.646-95%187.545-94%
Pb Ratio1.219-16%1.4141.200+18%1.593-11%0.818+73%-1.365+197%
Pe Ratio-2.790+14%-3.237-1.778-45%-10.697+230%-2.774-14%-2.307-29%
Price Per Share1.500-16%1.7401.717+1%3.088-44%1.753-1%2.110-18%
Price To Free Cash Flow Ratio-1.830+14%-2.123-1.774-16%-3.570+68%-2.063-3%-3.098+46%
Price To Total Gains Ratio-26.126+14%-30.306-9.245-69%-6.276-79%-5.488-82%1292.654-102%
Quick Ratio--5.4246.574-17%40.514-87%18.316-70%8.937-39%
Return On Assets---0.075-0.150+100%-0.215+187%-0.573+665%-1.119+1394%
Return On Equity---0.109-0.212+94%-0.226+107%-0.171+56%-0.083-24%
Total Gains Per Share---0.057-0.186+225%-0.151+163%0.163-135%0.057-201%
Usd Book Value--9991916.00011764776.333-15%13637260.250-27%3759750.842+166%-1479542.769+115%
Usd Book Value Change Per Share---0.099-0.208+109%-0.151+52%0.159-162%0.055-279%
Usd Book Value Per Share--1.2301.552-21%1.971-38%0.520+137%-0.225+118%
Usd Dividend Per Share--0.0420.021+97%-+100%0.003+1148%0.002+2463%
Usd Eps---0.134-0.317+136%-0.375+179%-0.685+410%-0.530+295%
Usd Free Cash Flow---1664260.000-1960833.667+18%-1637183.500-2%-1312180.579-21%-1251886.692-25%
Usd Free Cash Flow Per Share---0.205-0.258+26%-0.237+15%-0.186-9%-0.179-13%
Usd Free Cash Flow To Equity Per Share---0.2050.104-298%-0.125-39%0.422-149%0.217-194%
Usd Market Cap10379880.000-36%14131408.26013389180.277+6%21365253.000-34%12366161.100+14%14717574.191-4%
Usd Price Per Share1.500-16%1.7401.717+1%3.088-44%1.753-1%2.110-18%
Usd Profit---1091416.000-2447744.333+124%-3123404.750+186%-3590839.632+229%-3094405.923+184%
Usd Revenue--233600.000119233.333+96%32550.000+618%40789.474+473%46897.949+398%
Usd Total Gains Per Share---0.057-0.186+225%-0.151+163%0.163-135%0.057-201%
 EOD+3 -5MRQTTM+23 -15YOY+18 -205Y+21 -1710Y+16 -21

3.3 Fundamental Score

Let's check the fundamental score of BioRestorative Therapies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.790
Price to Book Ratio (EOD)Between0-11.219
Net Profit Margin (MRQ)Greater than0-4.672
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.424
Current Ratio (MRQ)Greater than12.949
Debt to Asset Ratio (MRQ)Less than10.314
Debt to Equity Ratio (MRQ)Less than10.459
Return on Equity (MRQ)Greater than0.15-0.109
Return on Assets (MRQ)Greater than0.05-0.075
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of BioRestorative Therapies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.823
Ma 20Greater thanMa 501.509
Ma 50Greater thanMa 1001.583
Ma 100Greater thanMa 2001.592
OpenGreater thanClose1.480
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About BioRestorative Therapies Inc

BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs relate to the treatment of disc/spine disease and metabolic disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is based in Melville, New York.

Fundamental data was last updated by Penke on 2024-11-19 00:53:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biorestorative earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • A Net Profit Margin of -467.2% means that $-4.67 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioRestorative Therapies Inc:

  • The MRQ is -467.2%. The company is making a huge loss. -2
  • The TTM is -3,780.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-467.2%TTM-3,780.3%+3,313.0%
TTM-3,780.3%YOY-31,527.5%+27,747.2%
TTM-3,780.3%5Y-36,337.3%+32,557.0%
5Y-36,337.3%10Y-24,577.4%-11,759.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-467.2%-112.2%-355.0%
TTM-3,780.3%-221.4%-3,558.9%
YOY-31,527.5%-210.0%-31,317.5%
5Y-36,337.3%-342.2%-35,995.1%
10Y-24,577.4%-464.5%-24,112.9%
4.3.1.2. Return on Assets

Shows how efficient Biorestorative is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • -7.5% Return on Assets means that Biorestorative generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioRestorative Therapies Inc:

  • The MRQ is -7.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.5%TTM-15.0%+7.5%
TTM-15.0%YOY-21.5%+6.6%
TTM-15.0%5Y-57.3%+42.4%
5Y-57.3%10Y-111.9%+54.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-11.3%+3.8%
TTM-15.0%-11.7%-3.3%
YOY-21.5%-11.3%-10.2%
5Y-57.3%-12.7%-44.6%
10Y-111.9%-14.1%-97.8%
4.3.1.3. Return on Equity

Shows how efficient Biorestorative is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • -10.9% Return on Equity means Biorestorative generated $-0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioRestorative Therapies Inc:

  • The MRQ is -10.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.9%TTM-21.2%+10.3%
TTM-21.2%YOY-22.6%+1.4%
TTM-21.2%5Y-17.1%-4.1%
5Y-17.1%10Y-8.3%-8.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.9%-14.2%+3.3%
TTM-21.2%-15.9%-5.3%
YOY-22.6%-14.3%-8.3%
5Y-17.1%-18.5%+1.4%
10Y-8.3%-19.3%+11.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioRestorative Therapies Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biorestorative is operating .

  • Measures how much profit Biorestorative makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioRestorative Therapies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-4,837.2%+4,837.2%
TTM-4,837.2%YOY-40,032.0%+35,194.8%
TTM-4,837.2%5Y-37,013.5%+32,176.3%
5Y-37,013.5%10Y-23,814.9%-13,198.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM-4,837.2%-310.7%-4,526.5%
YOY-40,032.0%-223.5%-39,808.5%
5Y-37,013.5%-387.1%-36,626.4%
10Y-23,814.9%-498.5%-23,316.4%
4.3.2.2. Operating Ratio

Measures how efficient Biorestorative is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 10.79 means that the operating costs are $10.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 10.790. The company is inefficient in keeping operating costs low. -1
  • The TTM is 52.635. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ10.790TTM52.635-41.845
TTM52.635YOY402.771-350.136
TTM52.6355Y214.646-162.010
5Y214.64610Y187.545+27.101
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.7902.465+8.325
TTM52.6353.253+49.382
YOY402.7713.298+399.473
5Y214.6464.788+209.858
10Y187.5456.494+181.051
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioRestorative Therapies Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biorestorative is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.95 means the company has $2.95 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 2.949. The company is able to pay all its short-term debts. +1
  • The TTM is 3.544. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.949TTM3.544-0.596
TTM3.544YOY22.467-18.922
TTM3.5445Y13.497-9.953
5Y13.49710Y6.596+6.901
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9493.637-0.688
TTM3.5443.890-0.346
YOY22.4674.666+17.801
5Y13.4975.953+7.544
10Y6.5966.277+0.319
4.4.3.2. Quick Ratio

Measures if Biorestorative is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • A Quick Ratio of 5.42 means the company can pay off $5.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 5.424. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.574. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.424TTM6.574-1.150
TTM6.574YOY40.514-33.940
TTM6.5745Y18.316-11.741
5Y18.31610Y8.937+9.378
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4243.086+2.338
TTM6.5743.451+3.123
YOY40.5144.456+36.058
5Y18.3165.931+12.385
10Y8.9376.436+2.501
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioRestorative Therapies Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biorestorative assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biorestorative to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.31 means that Biorestorative assets are financed with 31.4% credit (debt) and the remaining percentage (100% - 31.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 0.314. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.279. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.314TTM0.279+0.036
TTM0.279YOY0.054+0.225
TTM0.2795Y3.758-3.479
5Y3.75810Y4.444-0.686
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3140.350-0.036
TTM0.2790.344-0.065
YOY0.0540.310-0.256
5Y3.7580.365+3.393
10Y4.4440.382+4.062
4.5.4.2. Debt to Equity Ratio

Measures if Biorestorative is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biorestorative to the Biotechnology industry mean.
  • A Debt to Equity ratio of 45.9% means that company has $0.46 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioRestorative Therapies Inc:

  • The MRQ is 0.459. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.396. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.459TTM0.396+0.062
TTM0.396YOY0.058+0.339
TTM0.3965Y0.084+0.312
5Y0.08410Y0.041+0.043
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4590.394+0.065
TTM0.3960.432-0.036
YOY0.0580.380-0.322
5Y0.0840.451-0.367
10Y0.0410.490-0.449
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biorestorative generates.

  • Above 15 is considered overpriced but always compare Biorestorative to the Biotechnology industry mean.
  • A PE ratio of -3.24 means the investor is paying $-3.24 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioRestorative Therapies Inc:

  • The EOD is -2.790. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.237. Based on the earnings, the company is expensive. -2
  • The TTM is -1.778. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.790MRQ-3.237+0.446
MRQ-3.237TTM-1.778-1.459
TTM-1.778YOY-10.697+8.919
TTM-1.7785Y-2.774+0.996
5Y-2.77410Y-2.307-0.467
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.790-2.253-0.537
MRQ-3.237-2.411-0.826
TTM-1.778-3.149+1.371
YOY-10.697-3.274-7.423
5Y-2.774-6.143+3.369
10Y-2.307-6.785+4.478
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioRestorative Therapies Inc:

  • The EOD is -1.830. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.123. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.774. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.830MRQ-2.123+0.293
MRQ-2.123TTM-1.774-0.349
TTM-1.774YOY-3.570+1.797
TTM-1.7745Y-2.063+0.289
5Y-2.06310Y-3.098+1.035
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.830-3.009+1.179
MRQ-2.123-3.259+1.136
TTM-1.774-3.730+1.956
YOY-3.570-4.574+1.004
5Y-2.063-8.371+6.308
10Y-3.098-9.287+6.189
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biorestorative is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.41 means the investor is paying $1.41 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioRestorative Therapies Inc:

  • The EOD is 1.219. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.414. Based on the equity, the company is underpriced. +1
  • The TTM is 1.200. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.219MRQ1.414-0.195
MRQ1.414TTM1.200+0.214
TTM1.200YOY1.593-0.393
TTM1.2005Y0.818+0.382
5Y0.81810Y-1.365+2.183
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.2191.979-0.760
MRQ1.4142.051-0.637
TTM1.2002.365-1.165
YOY1.5932.455-0.862
5Y0.8183.726-2.908
10Y-1.3654.378-5.743
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of BioRestorative Therapies Inc.

4.8.1. Institutions holding BioRestorative Therapies Inc

Institutions are holding 13.48% of the shares of BioRestorative Therapies Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Geode Capital Management, LLC0.75630523371188029.3645
2024-06-30StoneX Group Inc0.7240.01501001525043.759
2024-06-30Wealth Alliance, LLC0.5780.01054000000
2024-06-30Morgan Stanley - Brokerage Accounts0.43350300001000050
2024-06-30UBS Group AG0.4019027813269733211.0714
2024-09-30Vanguard Group Inc0.295802047200
2024-06-30State Street Corp0.295702045900
2024-09-30Renaissance Technologies Corp0.2890.000120000200000
2024-09-30US FINANCIAL ADVISORS, LLC0.24770.00931714200
2024-09-30Newman Dignan & Sheerar Inc0.15210.00410522105220
2024-06-30Tower Research Capital LLC0.06930.00024795213480.1954
2024-06-30Wells Fargo & Co0.01390965-515-34.7973
2024-06-30Advisor Group Holdings, Inc.0.00280193-2001-91.2033
2024-06-30Bank of America Corp0.0007047470
2024-06-30Jjj Advisors Inc00110
2024-06-30Sabby Management LLC000-168544-100
2024-06-30Two Sigma Investments LLC000-18167-100
Total 4.26070.0341294846-92420-31.3%

4.9.2. Funds holding BioRestorative Therapies Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Fidelity Extended Market Index0.43640.000130201-1565-4.9267
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr0.295802047200
2024-09-30Fidelity Total Market Index0.194901348500
2024-09-30Fidelity Series Total Market Index0.101069875602404.4765
2024-09-30Fidelity Nasdaq Composite Index0.05580386200
2024-09-30NT Ext Equity Mkt Idx Fd - L0.03510.0001243100
2024-09-30Northern Trust Extended Eq Market Idx0.03510.0001243100
2024-09-30Spartan Total Market Index Pool E0.01510104300
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00540.000137510.2674
2024-09-30Spartan Extended Market Index Pool E0.001801281280
Total 1.17640.000481415+4166+5.1%

5.3. Insider Transactions

Insiders are holding 26.325% of the shares of BioRestorative Therapies Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-08Francisco SilvaBUY17081.16
2024-02-09Dale BroadrickBUY860411.32
2024-02-07Dale BroadrickBUY363741.38
2023-12-01Dale BroadrickSELL2501.88
2023-11-27Dale BroadrickSELL2781.89
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets14,573
Total Liabilities4,582
Total Stockholder Equity9,992
 As reported
Total Liabilities 4,582
Total Stockholder Equity+ 9,992
Total Assets = 14,573

Assets

Total Assets14,573
Total Current Assets13,509
Long-term Assets1,065
Total Current Assets
Cash And Cash Equivalents 1,489
Short-term Investments 11,598
Net Receivables 165
Other Current Assets 256
Total Current Assets  (as reported)13,509
Total Current Assets  (calculated)13,509
+/-0
Long-term Assets
Property Plant Equipment 418
Intangible Assets 646
Long-term Assets  (as reported)1,065
Long-term Assets  (calculated)1,065
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,582
Long-term Liabilities0
Total Stockholder Equity9,992
Total Current Liabilities
Short-term Debt 42
Accounts payable 401
Other Current Liabilities 4,138
Total Current Liabilities  (as reported)4,582
Total Current Liabilities  (calculated)4,582
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -154,043
Other Stockholders Equity 164,020
Total Stockholder Equity (as reported)9,992
Total Stockholder Equity (calculated)9,978
+/- 14
Other
Cash and Short Term Investments 13,088
Common Stock Shares Outstanding 8,121
Liabilities and Stockholders Equity 14,573
Net Debt -1,447
Net Working Capital 8,927
Short Long Term Debt Total 42



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-31
> Total Assets 
7,787
7,926
7,888
8,300
469
1,044
486
403
221
221
1,342
1,397
1,268
1,268
1,250
1,224
1,383
1,383
1,186
1,596
1,692
1,858
2,071
2,151
2,017
2,049
2,196
1,617
1,580
1,481
1,424
1,419
1,759
1,759
1,206
1,251
1,192
1,584
2,432
1,458
1,466
1,378
1,613
1,429
1,466
1,613
2,885
2,175
22,453
20,919
19,441
17,920
16,435
14,081
13,300
13,801
0
17,951
16,119
14,573
14,57316,11917,951013,80113,30014,08116,43517,92019,44120,91922,4532,1752,8851,6131,4661,4291,6131,3781,4661,4582,4321,5841,1921,2511,2061,7591,7591,4191,4241,4811,5801,6172,1962,0492,0172,1512,0711,8581,6921,5961,1861,3831,3831,2241,2501,2681,2681,3971,3422212214034861,0444698,3007,8887,9267,787
   > Total Current Assets 
0
0
0
0
18
0
65
64
0
118
47
129
0
31
66
66
0
240
95
422
114
180
246
385
289
384
546
33
62
38
47
36
520
520
76
182
181
647
1,357
201
69
53
344
214
69
344
1,829
1,170
21,468
19,879
18,324
16,888
15,128
12,783
12,044
12,604
0
16,770
15,004
13,509
13,50915,00416,770012,60412,04412,78315,12816,88818,32419,87921,4681,1701,8293446921434453692011,357647181182765205203647386233546384289385246180114422952400666631012947118064650180000
       Cash And Cash Equivalents 
0
108
46
31
18
506
7
15
71
72
13
104
0
0
0
1
201
201
59
374
92
146
6
13
167
353
516
6
32
9
2
1
452
452
4
105
118
496
1,284
98
2
5
298
176
2
298
1,759
1,130
21,027
19,323
17,934
6,573
1,677
1,836
1,784
2,437
0
1,157
2,252
1,489
1,4892,2521,15702,4371,7841,8361,6776,57317,93419,32321,0271,1301,759298217629852981,2844961181054452452129326516353167136146923745920120110001041372711575061831461080
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,914
13,073
10,538
9,832
9,802
0
15,261
12,428
11,598
11,59812,42815,26109,8029,83210,53813,0739,914000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
29
93
9
16
5
6
7
20
16
38
38
37
26
29
29
31
38
32
26
19
15
32
19
15
8
5
16
16
45
16
16
25
39
0
35
27
165
16527350392516164516165815193215192632383129292637383816207651699329510000000000000000000000
       Inventory 
0
0
12
13
0
0
0
0
0
0
0
0
13
12
14
18
18
18
18
17
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000002222171818181814121300000000131200
   > Long-term Assets 
0
0
0
0
450
0
420
339
0
103
1,295
1,268
0
1,237
1,184
1,158
0
1,143
1,091
1,175
1,577
1,678
1,824
1,766
1,728
1,665
1,650
1,584
1,518
1,442
1,377
1,382
0
1,239
1,130
1,069
1,011
937
1,075
1,257
1,397
1,325
1,269
1,215
1,397
1,269
1,056
1,005
986
1,040
1,117
1,032
1,306
1,298
1,256
1,197
0
1,181
1,115
1,065
1,0651,1151,18101,1971,2561,2981,3061,0321,1171,0409861,0051,0561,2691,3971,2151,2691,3251,3971,2571,0759371,0111,0691,1301,23901,3821,3771,4421,5181,5841,6501,6651,7281,7661,8241,6781,5771,1751,0911,14301,1581,1841,23701,2681,295103033942004500000
       Property Plant Equipment 
112
135
147
573
447
429
412
331
95
95
79
69
60
59
41
33
36
36
18
74
494
537
702
663
643
599
602
556
509
463
417
370
328
328
257
214
175
141
136
106
0
604
35
29
658
567
429
397
396
469
567
502
503
517
498
461
0
480
424
418
418424480046149851750350256746939639742956765829356040106136141175214257328328370417463509556602599643663702537494741836363341596069799595331412429447573147135112
       Intangible Assets 
7,665
7,671
7,671
7,671
4
4
3
3
3
3
1,212
1,195
1,177
1,177
1,142
1,125
1,107
1,108
1,073
1,055
1,038
1,095
1,076
1,057
1,039
1,020
1,001
983
964
945
926
908
889
889
852
833
814
795
777
758
739
720
702
683
739
702
627
608
590
571
551
530
803
781
759
736
0
691
669
646
64666969107367597818035305515715906086277027396837027207397587777958148338528898899089269459649831,0011,0201,0391,0571,0761,0951,0381,0551,0731,1081,1071,1251,1421,1771,1771,1951,2123333447,6717,6717,6717,665
       Long-term Assets Other 
0
0
0
0
0
0
4
4
0
4
4
4
0
0
0
0
0
0
0
46
46
46
46
46
46
46
46
46
46
34
34
105
0
22
22
22
22
795
162
394
0
0
532
503
561
445
416
10
0
0
-1,117
-1,032
0
0
-1,256
0
0
10
22
0
0221000-1,25600-1,032-1,1170010416445561503532003941627952222222201053434464646464646464646460000000444044000000
> Total Liabilities 
305
277
291
864
1,213
2,488
2,968
3,747
3,907
3,907
5,600
6,475
6,410
6,410
6,986
7,858
8,068
8,068
8,335
8,054
8,580
9,253
4,951
5,927
5,925
5,590
6,201
6,088
6,580
6,202
7,139
8,109
8,596
8,595
11,074
10,189
9,833
9,237
11,375
13,887
14,242
18,914
16,054
16,522
14,242
16,054
6,694
7,054
856
762
856
916
603
594
896
975
2,607
3,448
5,320
4,582
4,5825,3203,4482,6079758965946039168567628567,0546,69416,05414,24216,52216,05418,91414,24213,88711,3759,2379,83310,18911,0748,5958,5968,1097,1396,2026,5806,0886,2015,5905,9255,9274,9519,2538,5808,0548,3358,0688,0687,8586,9866,4106,4106,4755,6003,9073,9073,7472,9682,4881,213864291277305
   > Total Current Liabilities 
305
277
291
443
1,016
2,335
2,814
3,747
3,907
3,907
5,600
6,475
2,816
2,816
3,354
7,858
7,503
7,503
8,258
7,428
8,525
8,922
4,920
5,465
5,612
5,590
5,698
5,549
5,845
6,059
6,994
8,045
8,353
8,353
10,648
8,923
9,255
8,728
11,143
13,715
13,721
18,416
882
1,374
13,721
882
1,326
873
364
494
622
717
440
470
813
933
2,607
3,448
5,320
4,582
4,5825,3203,4482,6079338134704407176224943648731,32688213,7211,37488218,41613,72113,71511,1438,7289,2558,92310,6488,3538,3538,0456,9946,0595,8455,5495,6985,5905,6125,4654,9208,9228,5257,4288,2587,5037,5037,8583,3542,8162,8166,4755,6003,9073,9073,7472,8142,3351,016443291277305
       Short-term Debt 
0
0
0
0
514
0
1,928
2,334
0
3,041
4,321
4,643
0
962
979
4,966
0
4,990
5,906
5,171
5,688
5,463
1,115
1,244
1,010
1,317
1,320
1,298
1,859
1,940
2,433
2,873
3,468
3,468
4,426
3,151
3,626
3,513
5,499
7,526
0
0
0
0
7,231
807
139
159
178
124
129
134
139
145
150
156
0
124
167
42
4216712401561501451391341291241781591398077,23100007,5265,4993,5133,6263,1514,4263,4683,4682,8732,4331,9401,8591,2981,3201,3171,0101,2441,1155,4635,6885,1715,9064,99004,96697996204,6434,3213,04102,3341,92805140000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,859
1,940
2,553
2,873
3,468
3,694
4,426
3,151
3,626
3,513
5,499
7,526
7,146
8,022
714
1,115
0
15
29
44
59
0
0
0
0
0
0
0
0
0
0
0
000000000005944291501,1157148,0227,1467,5265,4993,5133,6263,1514,4263,6943,4682,8732,5531,9401,8590000000000000000000000000000
       Accounts payable 
18
122
108
150
160
72
308
658
426
426
440
700
771
771
1,003
1,156
1,270
1,270
893
774
1,112
1,266
1,747
2,110
2,549
2,194
2,070
1,994
2,284
2,284
2,467
2,718
2,455
2,455
2,277
2,112
1,894
1,568
1,527
1,744
1,954
2,049
75
163
1,954
32
98
125
51
214
378
469
171
93
276
227
0
231
216
401
4012162310227276931714693782145112598321,954163752,0491,9541,7441,5271,5681,8942,1122,2772,4552,4552,7182,4672,2842,2841,9942,0702,1942,5492,1101,7471,2661,1127748931,2701,2701,1561,0037717717004404264266583087216015010812218
       Other Current Liabilities 
8
3
25
113
342
493
578
722
440
396
839
1,133
1,083
1,083
1,372
1,736
1,243
1,243
1,234
1,328
1,561
1,982
1,944
2,009
2,218
2,079
0
2,257
1,702
1,835
2,094
111
2,430
216
1,277
950
1,095
752
946
1,191
916
4,426
807
1,212
916
43
1,089
0
194
156
115
115
130
233
386
549
1,544
3,094
4,856
4,138
4,1384,8563,0941,54454938623313011511515619401,089439161,2128074,4269161,1919467521,0959501,2772162,4301112,0941,8351,7022,25702,0792,2182,0091,9441,9821,5611,3281,2341,2431,2431,7361,3721,0831,0831,1338393964407225784933421132538
   > Long-term Liabilities 
0
0
0
0
197
0
154
0
0
0
0
0
0
3,594
3,632
0
0
565
77
627
55
331
32
462
313
0
503
539
735
143
145
64
0
242
426
1,265
579
508
231
171
522
498
15,173
15,147
522
15,173
5,367
6,181
493
268
234
199
162
124
84
42
0
0
0
0
000042841241621992342684936,1815,36715,17352215,14715,1734985221712315085791,2654262420641451437355395030313462323315562777565003,6323,59400000015401970000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,270
4,712
5,004
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000005,0044,7124,27000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
41
34
0
4
5
24
2
40
11
0
3
52
437
5
25
2
48
5
19
75
55
20
31
14
0
0
14,700
14,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000014,70014,7000014312055751954822554375230114022454034410000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71
0
0
0
0
0
0
162
372
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000372162000000710000000000000000000000000000000
> Total Stockholder Equity
7,482
7,649
7,597
7,436
-744
0
-2,483
-3,344
0
-3,686
-4,258
-5,078
0
-5,142
-5,736
-6,634
0
-6,685
-7,149
-6,458
-6,888
-7,395
-2,881
-3,776
-3,908
-3,541
-4,005
-4,471
-5,000
-4,722
-5,715
-6,690
-6,837
-6,837
-9,868
-8,938
-8,641
-7,653
-8,942
-12,429
-12,776
-17,536
-14,441
-15,093
-12,776
-14,441
-3,809
-4,879
21,597
20,157
18,586
17,004
15,832
13,487
12,404
12,826
10,004
14,503
10,799
9,992
9,99210,79914,50310,00412,82612,40413,48715,83217,00418,58620,15721,597-4,879-3,809-14,441-12,776-15,093-14,441-17,536-12,776-12,429-8,942-7,653-8,641-8,938-9,868-6,837-6,837-6,690-5,715-4,722-5,000-4,471-4,005-3,541-3,908-3,776-2,881-7,395-6,888-6,458-7,149-6,6850-6,634-5,736-5,1420-5,078-4,258-3,6860-3,344-2,4830-7447,4367,5977,6497,482
   Common Stock
410
489
499
507
461
529
585
603
636
636
701
718
772
772
17
18
20
20
26
32
35
38
3
3
3
4
4
4
5
5
5
6
6
6
7
9
12
15
20
24
0
159
159
159
8
159
335
0
0
0
0
0
0
0
0
0
0
1
1
1
11100000000003351598159159159024201512976665554443333835322620201817772772718701636636603585529461507499489410
   Retained Earnings Total Equity0000000000000-109,559-105,496-86,121-84,082-83,245000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0-14-140-14000000-1500-879000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,645
68,829
68,425
102,484
105,415
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000105,415102,48468,42568,82968,645000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000-49-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-32-61-20-200
   Other Stockholders Equity 
0
0
0
0
2,245
0
2,701
2,835
0
3,202
5,706
6,347
0
8,147
11,125
11,530
0
13,108
15,641
17,426
18,477
19,727
25,697
26,425
29,412
32,266
34,060
35,427
36,955
40,019
41,772
42,849
0
44,562
47,552
51,405
55,269
60,138
63,000
64,567
0
0
0
0
65,786
68,645
105,415
108,864
155,743
159,103
162,207
165,282
168,457
171,797
173,695
177,057
0
163,411
163,736
164,020
164,020163,736163,4110177,057173,695171,797168,457165,282162,207159,103155,743108,864105,41568,64565,786000064,56763,00060,13855,26951,40547,55244,562042,84941,77240,01936,95535,42734,06032,26629,41226,42525,69719,72718,47717,42615,64113,108011,53011,1258,14706,3475,7063,20202,8352,70102,2450000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.